These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
98 related articles for article (PubMed ID: 2220867)
1. Reducing costs by adjusting dosage intervals for intravenous ranitidine. Holt RT; Graves LJ; Scheil E Am J Hosp Pharm; 1990 Sep; 47(9):2068-9. PubMed ID: 2220867 [No Abstract] [Full Text] [Related]
2. Adjusting dosage intervals of intermittent intravenous ranitidine according to creatinine clearance: a cost-minimization analysis. Connelly JF Hosp Pharm; 1994 Nov; 29(11):992, 996-8, 1001. PubMed ID: 10138581 [TBL] [Abstract][Full Text] [Related]
3. Pharmacist intervention program focused on i.v. ranitidine therapy. Santora J; Kitrenos JG; Green ER Am J Hosp Pharm; 1990 Jun; 47(6):1346-9. PubMed ID: 2368729 [TBL] [Abstract][Full Text] [Related]
4. Formulary status of intravenous immunoglobulins in selected hospitals. Hatton RC; Doering PL; Fakhoury M; Williams RB Am J Hosp Pharm; 1988 Nov; 45(11):2377-9. PubMed ID: 3228096 [No Abstract] [Full Text] [Related]
5. Controlling cephalosporin and aminoglycoside costs through pharmacy and therapeutics committee restrictions. Hayman JN; Sbravati EC Am J Hosp Pharm; 1985 Jun; 42(6):1343-7. PubMed ID: 4014250 [TBL] [Abstract][Full Text] [Related]
6. Key inventory to formulary to cut drug costs. Schmieding JL; Sita MJ Hospitals; 1980 Sep; 54(17):78-81. PubMed ID: 7399457 [TBL] [Abstract][Full Text] [Related]
7. Use of concurrent monitoring and a preprinted note to modify prescribing of i.v. cimetidine and ranitidine in a teaching hospital. Dannenhoffer MA; Slaughter RL; Hunt SN Am J Hosp Pharm; 1989 Aug; 46(8):1570-5. PubMed ID: 2773962 [TBL] [Abstract][Full Text] [Related]
8. [Hospital essential drugs in Africa. An example of pharmacoeconomic research]. Meillon C; Stum N; Cuisinier-Raynal JC Dakar Med; 1996; Spec No():19-20. PubMed ID: 14520980 [No Abstract] [Full Text] [Related]
9. Experience with a two-tiered therapeutic interchange policy. Rich DS Am J Hosp Pharm; 1989 Sep; 46(9):1792-8. PubMed ID: 2572167 [TBL] [Abstract][Full Text] [Related]
10. Some research opportunities in hospital pharmacy. Wertheimer AI Am J Hosp Pharm; 1981 Oct; 38(10):1534-6. PubMed ID: 7294056 [TBL] [Abstract][Full Text] [Related]
11. An analysis of potential and real cost savings by the addition of ranitidine to total parenteral nutrition solutions. Pearson VE; King LM Hosp Pharm; 1992 Jul; 27(7):610, 613-4. PubMed ID: 10119189 [TBL] [Abstract][Full Text] [Related]
12. An informed M.D can help control drug costs. Souhrada L Hospitals; 1989 Jun; 63(12):78. PubMed ID: 2731927 [No Abstract] [Full Text] [Related]
13. Integration of clinical and administrative strategies to reduce expenditures for antimicrobial agents. Hess DA; Mahoney CD; Johnson PN; Corrao WM; Fisher AE Am J Hosp Pharm; 1990 Mar; 47(3):585-91. PubMed ID: 2316543 [TBL] [Abstract][Full Text] [Related]
14. Pharmacoeconomic considerations in rural hospitals. Lenhert P Cost Qual Q J; 1998 Jun; 4(2):37-42. PubMed ID: 10182598 [No Abstract] [Full Text] [Related]
15. Purchasing and inventory control--past, present, and future. Skolaut MW; McAllister JC Am J Hosp Pharm; 1984 Mar; 41(3):522-5. PubMed ID: 6702857 [TBL] [Abstract][Full Text] [Related]